Etamsylate acts on the first step of hemostasis by improving platelet adhesiveness and restoring capillary resistance. It prevents the break down of the capillary wall by its anti-hyaluronidase activity and inhibits prostacycline synthetase which is a powerful vasodilator. It also augments fibrin formation by increasing the generation of thromboplastin and helps in stable fibrin clot formation.

Menorrhahagia, Metrorrhagia, DUB, Post-Partum Haemorrhage, IUCD induced menorrhagia, bleeding haemorrhoids, Epistaxis, Prostatic surgery, tooth extraction, Tonsillectomy.

Drug Composition:
Each uncoated tablet contains 250 mg & 500 mg etamsylate Injection ampoule: Each 2ml ampoule contains 250 mg Etamsylate.

1 Tablet TID and 250-500 mg I.M / I.V every 4-6 Hourly till bleeding Persist.

Pregnancy, hypersensitivity and porphyria (a blood disorder).

Patients with history of coeliac disease, during pregnancy and breastfeeding.

This product is currently only available in India against valid prescription from a Registered Medical Practitioner. This is not an offer for sale.

Stadmed Private Limited
P: +91 247-40-650/651/653